Thursday, December 27, 2018

BioXcel Therapeutics (BTAI) Granted FDA Fast Track Designation for BXCL501 for Acute Treatment of Agitation - https://t.co/gM21sWkdr3 https://t.co/CW572zrnQg


from Twitter https://twitter.com/IDROOhio

December 27, 2018 at 12:01PM

No comments:

Post a Comment